SCHEMBL30751518

SCHEMBL30751518

CNC(=O)c1cnc(N2CCN(C(C)=O)CC2C)nc1Nc1ccccc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HPGD P15428 2/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ ULK1 O75385 1/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ JAK2 O60674 2/20 0.42
▸ JAK1 P23458 1/20 0.42
▸ TYK2 P29597 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ ALK Q9UM73 8/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31673033 0.90 MAP4K1 (0.51) MAPTUSP2ALOX15TSHRSMN1; SMN2
SCHEMBL30751498 0.89 GPR119 (0.46) MAPTUSP2ALOX15TSHRSMN1; SMN2
SCHEMBL30751549 0.85 TYK2 (0.47) MAPK1JAK2JAK1TYK2PDE4D
SCHEMBL30751571 0.83 TYK2 (0.47) JAK1TYK2
Hydrochloric Acid SCHEMBL31673026 0.83 BRPF1 (0.45) MAPTUSP2ALOX15TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL31673016 0.83 BRPF1 (0.45) MAPTUSP2ALOX15TSHRSMN1; SMN2
SCHEMBL30751554 0.82 PTPN11 (0.47) MAPTUSP2ALOX15TSHRSMN1; SMN2
SCHEMBL30751488 0.80 JAK2 (0.49) HPGDCASP1JAK2JAK1TYK2
SCHEMBL31673039 0.79 SYK (0.41) JAK2JAK1ALKMETSYK
SCHEMBL30751553 0.77 GPR119 (0.53) JAK2JAK1TYK2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS 1910 GENETICS INC (US) 2025-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS TYK2, PDXK, JAK1 MAPT 943/4885USP2 3751/4885ALOX15 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback